Cost-Utility Analysis of Certolizumab Pegol for the Treatment of Active Psoriatic Arthritis in GREECE

Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.2319
https://www.valueinhealthjournal.com/article/S1098-3015(15)04395-8/fulltext
Title : Cost-Utility Analysis of Certolizumab Pegol for the Treatment of Active Psoriatic Arthritis in GREECE
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)04395-8&doi=10.1016/j.jval.2015.09.2319
First page : A646
Section Title : Research Podium Presentations - Session 1 and Session 2
Open access? : No
Section Order : 1725
Categories :
Tags :
Regions :
ViH Article Tags :